Book 10 Section III.indd

Neurology and Psychiatry III Panel Editorial Board Liaison

Inflammatory Neuropathies

Jeffrey T. Sherer, Pharm.D., MPH, BCPS Clinical Associate Professor Department of Clinical Sciences and Administration University of Houston College of Pharmacy Houston, Texas

Author Benson H. Sederholm, Pharm.D., BCPS Clinical Pharmacist, Neurosciences Department of Pharmacy Services University of Utah Hospital Adjunct Assistant Professor Department of Pharmacotherapy University of Utah Salt Lake City, Utah

Management of Acute Traumatic Brain Injury Authors

Reviewers

G. Christopher Wood, Pharm.D., FCCP, BCPS, (AQ Infectious Diseases) Associate Professor Department of Clinical Pharmacy University of Tennessee College of Pharmacy Memphis, Tennessee

Travis E. Sonnett, Pharm.D., FASCP Clinical Assistant Professor Department of Pharmacotherapy Washington State University College of Pharmacy Clinical Pharmacy Specialist Department of Pharmacy Spokane VA Medical Center Spokane, Washington

Bradley A. Boucher, Pharm.D., FCCP, FCCM, BCPS Professor of Clinical Pharmacy Department of Clinical Pharmacy Associate Professor of Neurosurgery Department of Neurosurgery University of Tennessee Memphis, Tennessee Reviewers

Brian A. Hemstreet, Pharm.D., BCPS Associate Professor Director, Pharmaceutical Care Learning Center Department of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora, Colorado

Teresa A. Allison, Pharm.D., BCPS Clinical Specialist, Neurosciences Program Director, PGY2 Critical Care Residency Department of Pharmacy Services Memorial Hermann – Texas Medical Center Houston, Texas

Phuonglinh Morsches, Pharm.D., BCPS Assistant Professor Department of Pharmacy Practice Texas A&M Health Science Center College of Pharmacy Houston, Texas

Katherine Hammond Chessman, Pharm.D., FCCP, BCPS, BCNSP Professor Department of Clinical Pharmacy and Outcome Sciences Pediatric Pharmacy Practice Residency Program Director South Carolina College of Pharmacy Medical University of South Carolina Campus Clinical Pharmacy Specialist Pediatrics/Pediatric Surgery MUSC Children’s Hospital Charleston, South Carolina

PSAP-VII • Neurology and Psychiatry

Rating Scales in Psychiatric Disorders Author Megan Ehret, Pharm.D., BCPP Assistant Professor Department of Pharmacy Practice University of Connecticut Storrs, Connecticut

135

Neurology and Psychiatry III

Reviewers Mitsi H. Lizer, Pharm.D., BCPP Associate Professor Department of Pharmacy Practice Bernard J. Dunn School of Pharmacy Shenandoah University Winchester, Virginia Marisel Segarra-Newnham, Pharm.D., MPH, FCCP, BCPS Clinical Pharmacy Specialist, Infectious Diseases Pharmacy Service Veterans Affairs Medical Center West Palm Beach, Florida Clinical Assistant Professor of Pharmacy Practice University of Florida College of Pharmacy Gainesville, Florida Julia K. Nguyen, Pharm.D., BCPS, CGP Pharmacist Specialist Kaiser Permanente Panorama City Medical Center Panorama City, California Assistant Clinical Professor University of California San Francisco School of Pharmacy San Francisco, California The American College of Clinical Pharmacy and the authors thank the following individuals for their careful review of the Book 10, Neurology and Psychiatry III chapters: H. Gwen Bartlett, Pharm.D., BCPS Clinical Pharmacist III Department of Pharmacy St. Francis Health Center Topeka, Kansas Mary Lee, Pharm.D., FCCP, BCPS Vice President and Chief Academic Officer Pharmacy and Health Sciences Education Midwestern University Professor of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois

Neurology and Psychiatry III

136

PSAP-VII • Neurology and Psychiatry

Disclosure of Potential Conflicts of Interest Consultancies: Bradley Boucher (Eisai Corporation, Zymogenetics/Bristol-Meyers Squibb); Clarence Chant (Sunovion Canada); Jack J. Chen (Chelsea Pharmaceuticals, Ipsen Group, Teva Neuroscience); Megan Ehret (College of Psychiatric and Neurologic Pharmacists); Linda Farho (Nebraska Department of Health and Human Services); Shannon W. Finks (Novartis Pharmaceuticals); Dawn Knudsen Gerber (Arizona Pharmacy Alliance [AzPA], Banner MediSun); Brian A. Hemstreet (Conexus Health); Lisa C. Hutchison (Arkansas Medicaid, Arkansas Foundation for Medical Care); Mitsi Lizer (National Alliance on Mental Illness – Winchester, Va.); Cynthia A. Mascarenas (Abbott Laboratories); Timothy J. Reilly (MedERRS, McMahon Publishing Group); Michelle Richardson (Amgen, QualityMetric); Marisel Segarra-Newnham (Tibotec Therapeutics, USP, Annals of Pharmacotherapy); Jeffrey T. Sherer (Sturge-Weber Foundation); G. Christopher Wood (Ortho-McNeil, Bayer AG)

Lizer (Shenandoah University); Cynthia A. Mascarenas (Forest Pharmaceuticals); Christopher W. Miller (Cardinal Health); Troy A. Moore (University of Texas Health Science Center at San Antonio); Julia K. Nguyen (Kaiser Permanente); Timothy J. Reilly (Rutgers University Faculty Research Grant Program) Honoraria: Kathleen A. Baldwin (University of Florida Pharmacy School); Bradley Boucher (Eisai Corporation, Zymogenetics/ Bristol-Meyers Squibb); Clarence Chant (Hospira Canada and Drug Intelligence Inc.); Jack J. Chen (Ipsen Group, Teva Neuroscience); Dawn Knudsen Gerber (Teva Neuroscience, Pfizer [spouse or significant other]); Lisa C. Hutchison (American College of Clinical Pharmacy, American Society of Health-System Pharmacists); Cynthia A. Mascarenas (College of Psychiatric and Neurologic Pharmacists, American Society of Health-System Pharmacists); Christopher W. Miller (Texas A&M Lecture Series); Joy R. Miller (Texas A&M College of Pharmacy [two honoraria]); Timothy J. Reilly (New Jersey Society of Health-System Pharmacists, New Jersey Pharmacists’ Association); Michelle Richardson (Amgen); G. Christopher Wood (Forest Pharmaceuticals)

Stock Ownership: Katherine H. Chessman (Procter & Gamble [spouse or significant other]); Lisa C. Hutchison (Cardinal Health); Xi Liu-DeRyke (Optimer Pharmaceuticals); Timothy J. Reilly (Johnson & Johnson [spouse or significant other]

Other: Timothy J. Reilly (Spouse or significant other employed by Johnson & Johnson)

Royalties: Lisa C. Hutchison (ASHP) Grants: Jack J. Chen (Teva Neuroscience); Megan Ehret (American Society of Health-System Pharmacists); Linda Sobeski Farho (UNMC Board of Regents [two grants]); Dawn Knudsen Gerber (Midwestern University College of Pharmacy – Glendale); Brian A. Hemstreet (AstraZeneca); Anne L. Hume (AHRQ [two grants], HRSA); Lisa C. Hutchison (Boehringer Ingelheim, National Institutes of Health); Mitsi

Nothing to Disclose: Teresa A. Allison; William L. Baker; Laura Cummings; Danielle C. Ezzo; Olga Hilas; Katie L. Holliday; Emilie Karpiuk; Marianne McCollum; Phuonglinh Morsches; Karla M. Miller; Lisa J. Miller; Sarah Mullarkey; Benson H. Sederholm; Travis E. Sonnett; Jessica A. Starr; Melissa M. Tiedeman

ROLE OF BPS: The Board of Pharmacy Specialties (BPS) is an autonomous division of the American Pharmacists Association (APhA). BPS is totally separate and distinct from ACCP. The Board, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. PSAP has been approved by BPS for use in BCPS recertification. Information about the BPS recertification process is available at www.bpsweb.org/recertification/general.cfm.

ROLE OF ACCP: ACCP developed the petition seeking recognition of Pharmacotherapy as a specialty of pharmacy and presented it to the Board of Pharmacy Specialties (BPS). As part of its mission to provide leadership, education, advocacy, and resources enabling clinical pharmacists to achieve excellence in practice and research, ACCP also helps pharmacotherapy specialists maintain their certification through PSAP. ACCP reports successful completion of PSAP examinations to BPS for recertification credit. Neither ACCP nor its agents, including the PSAP Editorial Board, authors, reviewers, or other staff, has knowledge of specific examination content, areas of emphasis, or any other information that would compromise the integrity of the examination process.

PSAP-VII • Neurology and Psychiatry

Other questions regarding recertification should be directed to: Board of Pharmacy Specialties 2215 Constitution Avenue NW Washington, DC 20037 (202) 429-7591 www.bpsweb.org

vii

Front Matter